Skip to content
‹ Back to IndustriesSciences

NASA Joins the International Effort to Learn More About Norway’s Auroral Cusp

A solar wind of ionized particles from the sun is constantly blowing through the solar system. Earth’s only protection from this wind is its magnetic field, which emerges from the north pole, wraps around the earth, and re-enters the earth at the south pole. Mars has no atmosphere because, after it lost its protective magnetic…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · ·
Share

Key takeaways

01

A solar wind of ionized particles from the sun is constantly blowing through the solar system.

02

Earth’s only protection from this wind is its magnetic field, which emerges from the north pole, wraps around the earth, and re-enters the earth at the south pole.

03

Mars has no atmosphere because, after it lost its protective magnetic…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

A solar wind of ionized particles from the sun is constantly blowing through the solar system. Earth’s only protection from this wind is its magnetic field, which emerges from the north pole, wraps around the earth, and re-enters the earth at the south pole. Mars has no atmosphere because, after it lost its protective magnetic field, the solar winds literally blew the atmosphere away. The earth’s active magnetic field is what keeps the same thing from happening here, and life disappearing from earth.

Near the poles, however, where the magnetic field bends in toward the earth, the solar wind can come into contact with the atmosphere, heating up the atmosphere and causing the auroras as the ionized particles bombard air molecules. According to Eureka Alert!, “North of Norway over the Norwegian and Greenland Seas, the magnetic bubble surrounding the Earth dips inward, allowing space particles to funnel in toward the planet.” This cusp, where energy from the solar wind “heats the atmosphere by hundreds of degrees,” is actually visible to the naked eye in November and December.

This is why “eight missions with 11 rockets will launch from two sites in Norway—Andøya Space Center and Svalbard Rocket Range” around this time in 2018 and 2019. “The first mission—a NASA mission called the Auroral Zone Upwelling Rocket Experiment, or AZURE—launches in March 2018.” NASA will also launch “the Visualizing Ion Outflow via Neutral Atom Sensing-2 experiment or VISIONS-2” in December 2018. There will also be the “Norwegian Investigation of Cusp Irregularities-5 or ICI-5 mission in December 2019.”

The Eureka Alert website further explains, “In addition to AZURE, VISIONS-2 and ICI-5, other NASA Grand Challenge missions are the Twin Rockets to Investigate Cusp Electrodynamics or TRICE-2 (led by the University of Iowa, launching December 2018), The Cusp Alfven and Plasma Electrodynamics Rocket or CAPER-2 (led by Dartmouth University, launching January 2019), and the Cusp-Region Experiment or C-REX 2 (led by the University of Alaska, launching November 2019), which also includes three Canadian instruments from the University of Calgary (also flying on VISIONS-2).” Furthermore, “The Japan Aerospace Exploration Agency (JAXA) will fly the SS-520-3 in January 2019, which investigates the ion outflow mechanism in the cusp.”

The next year will be exciting for both atmospheric and space science at the international level. By learning more about this unique feature in our atmosphere created by the earth’s magnetic field, we will learn more about the solar wind, how the solar wind interacts with the atmosphere, and how our magnetic field protects life on earth. So, stay tuned to science news over the next several years as new data surfaces and more knowledge about the cusp is created.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu names digitalization, personalization and large-volume delivery as the trends reshaping drug delivery devices, arguing structured data can end rebuilding design files for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of the injectable pipeline.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512